A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Idiopathic Pulmonary Fibrosis
In brief
To study the safety and effectiveness of multiple-doses of tralokinumab on pulmonary function in adults with mild to moderate idiopathic pulmonary fibrosis (IPF). IPF is a chronic, progressive, irreversible, and usually fatal lung disease of unknown cause.
Key facts
- Study ID
- NCT01629667
- Run by
- MedImmune LLC
- People needed
- 409
- Starts
- 2012-10-01
- Expected to finish
- 2016-01-01
- Last updated by the study team
- 2017-05-15
Who can join
Age: 50 and older, up to 79. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Phoenix, Arizona, United States
- Research Site — La Jolla, California, United States
- Research Site — Sacramento, California, United States
- Research Site — Tampa, Florida, United States
- Research Site — Winter Park, Florida, United States
- Research Site — Atlanta, Georgia, United States
- Research Site — Honolulu, Hawaii, United States
- Research Site — Chicago, Illinois, United States
- Research Site — Louisville, Kentucky, United States
- Research Site — Ann Arbor, Michigan, United States
- Research Site — Rochester, Minnesota, United States
- Research Site — Chesterfield, Missouri, United States
- Research Site — Summit, New Jersey, United States
- Research Site — Durham, North Carolina, United States
- Research Site — Hershey, Pennsylvania, United States
- Research Site — Philadelphia, Pennsylvania, United States
- Research Site — Charleston, South Carolina, United States
- Research Site — Nashville, Tennessee, United States
- Research Site — McAllen, Texas, United States
- Research Site — McKinney, Texas, United States
- Research Site — Salt Lake City, Utah, United States
- Research Site — Box Hill, Australia
- Research Site — Camperdown, Australia
- Research Site — Concord, Australia
- Research Site — Darlinghurst, Australia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.